Skip to main content
Fig. 9 | Biology Direct

Fig. 9

From: LINC01094 promotes gastric cancer through dual targeting of CDKN1A by directly binding RBMS2 and HDAC1

Fig. 9

RUNX1 promotes LINC01094 expression and the regulative effect could be inhibited by Ro 5–3335. Notes A RUNX1 was predicted by the JASPAR database to bind with LINC01094 (top) and the potential binding region was visualized (bottom). B The expression of LINC01094 was positively correlated with that of RUNX1 according to the TCGA STAD database. C The association between the expression of LINC01094 and that of RUNX1 was validated by qRT-PCR. D A luciferase reporter assay was used to confirm that RUNX1 could promote the transcription of LINC01094. E The binding region between RUNX1 and LINC01094 was examined by a luciferase assay. F, G ChIP-qPCR indicated that RUNX1 could promote LINC0194 transcription by binding with site 2 and site 4 in the LINC01094 promoter. H, I RUNX1 could regulate CDKN1A expression by affecting LINC01094. J–R The effects of LINC01094 on malignant behaviors in vitro (J–O) and in vivo (P–S) could be affected by RUNX1 expression

Back to article page